Sitagliptin, anagliptin, gemigliptin, and teneligliptin form class 3 of the DPP-4 inhibitors (see Figure 2) ( Figure 2 The clinically most relevant and important action of DPP-4 inhibitors is the endogenous elevation of the incretin hormone concentration of GLP-1 that consecutively leads to a glucose-dependent stimulation of insulin secretion and an inhibition of glucagon secretion ( This article gives an overview on the characteristics of the various DPP-4 inhibitors in clinical use and highlights the positioning of the drug class in the guidelines for the treatment of type 2 diabetes
They touched on it to some extent in this article, but they need to do a lot more research looking at if they are directly affecting the brain or if its the weight loss and reduction in chronic inflammation thats actually helping
(2001) Kinetics of endomitosis in primary murine megakaryocytes J
However, adverse GI effects, particularly nausea, constipation, and dyspepsia, remain notable considerations
Pediatric Endocrinology Reviews
Furthermore, the scores for basal cell carcinoma images are 96.52%, 92.67%, and 93.78%, respectively